Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
Public ClinicalTrials.gov record NCT06449352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of the Addition of Netarsudil 0.02% vs. Brimonidine 0.1% in Normal Tension Glaucoma Patients Currently on Latanoprost 0.005%
Study identification
- NCT ID
- NCT06449352
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Westlake Eye Specialists
- Other
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Netarsudil Drug
- Brimonidine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2024
- Primary completion
- Sep 21, 2025
- Completion
- Sep 21, 2025
- Last update posted
- Oct 21, 2025
2024 – 2025
United States locations
- U.S. sites
- 4
- U.S. states
- 1
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Westlake Eye Specialists - Austin Office | Austin | Texas | 78746 | — |
| Westlake Eye Specialists - Killeen Office | Killeen | Texas | 76549 | — |
| Westlake Eye Specialists - Kyle Office | Kyle | Texas | 78640 | — |
| Westlake Eye Specialists - New Braunfels Office | New Braunfels | Texas | 78130 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06449352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 21, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06449352 live on ClinicalTrials.gov.